tradingkey.logo

SINTX Technologies Inc

SINT
查看详细走势图
3.610USD
+0.090+2.56%
收盘 12/19, 16:00美东报价延迟15分钟
13.05M总市值
亏损市盈率 TTM

SINTX Technologies Inc

3.610
+0.090+2.56%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.56%

5天

-2.17%

1月

+8.08%

6月

+14.60%

今年开始到现在

+3.14%

1年

+2.56%

查看详细走势图

TradingKey SINTX Technologies Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

SINTX Technologies Inc当前公司基本面数据相对健康,增长潜力稳定。当前估值合理,在医疗设备与耗材行业排名143/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价16.00。中期看,股价处于下降通道。近一个月,市场表现较强,但基本面和技术面综合得分较低,较强的走势没有得到基本面和技术面印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

SINTX Technologies Inc评分

相关信息

行业排名
143 / 208
全市场排名
368 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 1 位分析师
买入
评级
16.000
目标均价
+280.05%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

SINTX Technologies Inc亮点

亮点风险
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
业绩高增长
公司营业收入稳步增长,连续3年增长84.95%
业绩增长期
公司处于发展阶段,最新年度总收入2.89M美元
估值低估
公司最新PE估值-0.97,处于3年历史低位
机构加仓
最新机构持股265.99K股,环比增加14.72%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值30.43K

SINTX Technologies Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

SINTX Technologies Inc简介

SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
公司代码SINT
公司SINTX Technologies Inc
CEOOlson (Eric K)
网址https://sintx.com/

常见问题

SINTX Technologies Inc(SINT)的当前股价是多少?

SINTX Technologies Inc(SINT)的当前股价是 3.610。

SINTX Technologies Inc的股票代码是什么?

SINTX Technologies Inc的股票代码是SINT。

SINTX Technologies Inc股票的52周最高点是多少?

SINTX Technologies Inc股票的52周最高点是7.360。

SINTX Technologies Inc股票的52周最低点是多少?

SINTX Technologies Inc股票的52周最低点是1.710。

SINTX Technologies Inc的市值是多少?

SINTX Technologies Inc的市值是13.05M。

SINTX Technologies Inc的净利润是多少?

SINTX Technologies Inc的净利润为-11.02M。

现在SINTX Technologies Inc(SINT)的股票是买入、持有还是卖出?

根据分析师评级,SINTX Technologies Inc(SINT)的总体评级为买入,目标价格为16.000。

SINTX Technologies Inc(SINT)股票的每股收益(EPS TTM)是多少

SINTX Technologies Inc(SINT)股票的每股收益(EPS TTM)是-3.739。
KeyAI